129 related articles for article (PubMed ID: 17591314)
21. Recombinant factor VIIa for refractory bleeding following orthotopic heart transplantation.
Flynn JD; Pajoumand M; Camp PC; Jahania MS; Ramaiah C; Akers WS
Ann Pharmacother; 2004 Oct; 38(10):1639-42. PubMed ID: 15340124
[TBL] [Abstract][Full Text] [Related]
22. Recombinant activated factor VII (rFVIIa) treatment in infants with hemorrhage.
Brady KM; Easley RB; Tobias JD
Paediatr Anaesth; 2006 Oct; 16(10):1042-6. PubMed ID: 16972833
[TBL] [Abstract][Full Text] [Related]
23. Successful treatment of gastrointestinal bleeding with recombinant factor VIIa after kidney transplantation in patients with pancytopenia.
Malato A; Lo Monte AI; Anastasio R; Lo Coco L; Abbene I; Maione C; Gioviale MC; Siragusa S
Transplant Proc; 2006 May; 38(4):1031-3. PubMed ID: 16757254
[TBL] [Abstract][Full Text] [Related]
24. [The use of recombinant activated factor VII in a patient with uncontrolled bleeding from the gastrointestinal tract].
Vitković R; Petrović I
Srp Arh Celok Lek; 2008 Sep; 136 Suppl 3():246-8. PubMed ID: 19562877
[TBL] [Abstract][Full Text] [Related]
25. The use of recombinant activated factor VII to control bleeding in a preterm infant undergoing exploratory laparotomy.
Chuansumrit A; Nuntnarumit P; Okascharoen C; Teeraratkul S; Suwansingh S; Supapannachart S
Pediatrics; 2002 Jul; 110(1 Pt 1):169-71. PubMed ID: 12093965
[TBL] [Abstract][Full Text] [Related]
26. Treatment of massive cecal bleeding in a 28-Year-old patient with homozygous factor V deficiency with activated factor VII.
Petros S; Fischer J; Mössner J; Schiefke I; Teich N
Z Gastroenterol; 2008 Mar; 46(3):271-3. PubMed ID: 18322882
[TBL] [Abstract][Full Text] [Related]
27. Congenital factor VII deficiency: therapy with recombinant activated factor VII -- a critical appraisal.
Mariani G; Konkle BA; Ingerslev J
Haemophilia; 2006 Jan; 12(1):19-27. PubMed ID: 16409171
[TBL] [Abstract][Full Text] [Related]
28. Recombinant factor VIIa to control excessive bleeding following surgery for congenital heart disease in pediatric patients.
Tobias JD; Simsic JM; Weinstein S; Schechter W; Kartha V; Michler R
J Intensive Care Med; 2004; 19(5):270-3. PubMed ID: 15358945
[TBL] [Abstract][Full Text] [Related]
29. Efficacy of recombinant activated factor VII in unselected patients with uncontrolled haemorrhage: a single centre experience.
Payne EM; Brett SJ; Laffan MA
Blood Coagul Fibrinolysis; 2006 Jul; 17(5):397-402. PubMed ID: 16788316
[TBL] [Abstract][Full Text] [Related]
30. Massive pulmonary embolism after treatment with rFVIIa in a thrombocytopenic patient with acute myelogenous leukemia and intractable bleeding.
Mantzios G; Tsirigotis P; Pappa V; Spirou K; Giannopoulou V; Kaitsa I; Girkas K; Papageorgiou E; Dervenoulas J
Eur J Haematol; 2007 Feb; 78(2):173-4. PubMed ID: 17313564
[No Abstract] [Full Text] [Related]
31. [The use of recombinant activated factor VII in the treatment of gastrointestinal bleeding following acetylsalicylic acid therapy in a surgical patient].
Vucelić D; Sabljak P; Pesko P; Stojakov D; Keramatollah E; Nenadić B; Pejović D; Velicković D; Bjelović M
Srp Arh Celok Lek; 2008 Sep; 136 Suppl 3():240-5. PubMed ID: 19562876
[TBL] [Abstract][Full Text] [Related]
32. The use of recombinant factor VIIa in liver diseases.
Franchini M; Montagnana M; Targher G; Zaffanello M; Lippi G
Blood Coagul Fibrinolysis; 2008 Jul; 19(5):341-8. PubMed ID: 18600080
[TBL] [Abstract][Full Text] [Related]
33. Recombinant factor VIIa use in cardiac surgery--expanding the arsenal therapy for intractable bleeding?
Kogan A; Berman M; Stein M; Vidne BA; Raanani E
J Cardiovasc Surg (Torino); 2004 Dec; 45(6):569-71. PubMed ID: 15746637
[TBL] [Abstract][Full Text] [Related]
34. A novel hemostatic agent: the potential role of recombinant activated factor VII (rFVIIa) in anesthetic practice.
Murkin JM
Can J Anaesth; 2002 Dec; 49(10):S21-6. PubMed ID: 12546007
[TBL] [Abstract][Full Text] [Related]
35. Is the use of rFVIIa safe and effective in bleeding neonates? A retrospective series of 8 cases.
Mitsiakos G; Papaioannou G; Giougi E; Karagianni P; Garipidou V; Nikolaidis N
J Pediatr Hematol Oncol; 2007 Mar; 29(3):145-50. PubMed ID: 17356391
[TBL] [Abstract][Full Text] [Related]
36. Recombinant activated factor VII in refractory gastrointestinal haemorrhage of unknown aetiology.
Matic I; Titlic M; Lucic I; Mirkovic F; Jurjevic M
Bratisl Lek Listy; 2008; 109(10):438-40. PubMed ID: 19166127
[TBL] [Abstract][Full Text] [Related]
37. Management of thrombocytopenic bleeding: is there a role for recombinant coagulation factor VIIa?
Poon MC
Curr Hematol Rep; 2003 Mar; 2(2):139-47. PubMed ID: 12901145
[TBL] [Abstract][Full Text] [Related]
38. Massive oral bleeding after full-mouth extraction in a patient with B-cell lymphocytic leukemia/small lymphocytic lymphoma reversed with recombinant activated factor VII.
Sprenker C; Omar HR; Powless RA; Mangar D; Camporesi E
J Am Dent Assoc; 2016 Feb; 147(2):142-5. PubMed ID: 26562728
[TBL] [Abstract][Full Text] [Related]
39. Recombinant factor VIIa and the surgical patient.
Scarpelini S; Rizoli S
Curr Opin Crit Care; 2006 Aug; 12(4):351-6. PubMed ID: 16810047
[TBL] [Abstract][Full Text] [Related]
40. Role of recombinant activated factor VII in securing haemostatic failure in gun shot trauma.
Shamsi T; Tufail M; Aftab M; Ansari S
J Pak Med Assoc; 2006 May; 56(5):238-41. PubMed ID: 16767955
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]